[English] 日本語
Yorodumi- PDB-1ums: STROMELYSIN-1 CATALYTIC DOMAIN WITH HYDROPHOBIC INHIBITOR BOUND, ... -
+Open data
-Basic information
Entry | Database: PDB / ID: 1ums | ||||||
---|---|---|---|---|---|---|---|
Title | STROMELYSIN-1 CATALYTIC DOMAIN WITH HYDROPHOBIC INHIBITOR BOUND, PH 7.0, 32OC, 20 MM CACL2, 15% ACETONITRILE; NMR ENSEMBLE OF 20 STRUCTURES | ||||||
Components | STROMELYSIN-1 | ||||||
Keywords | HYDROLASE/HYDROLASE INHIBITOR / ZINC HYDROLASE / METZINCIN / MATRIX METALLOPROTEINASE / HYDROLASE-HYDROLASE INHIBITOR COMPLEX | ||||||
Function / homology | Function and homology information stromelysin 1 / cellular response to UV-A / regulation of neuroinflammatory response / Assembly of collagen fibrils and other multimeric structures / Activation of Matrix Metalloproteinases / response to amyloid-beta / Collagen degradation / collagen catabolic process / extracellular matrix disassembly / cellular response to nitric oxide ...stromelysin 1 / cellular response to UV-A / regulation of neuroinflammatory response / Assembly of collagen fibrils and other multimeric structures / Activation of Matrix Metalloproteinases / response to amyloid-beta / Collagen degradation / collagen catabolic process / extracellular matrix disassembly / cellular response to nitric oxide / negative regulation of reactive oxygen species metabolic process / negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction / regulation of cell migration / EGFR Transactivation by Gastrin / Degradation of the extracellular matrix / extracellular matrix organization / extracellular matrix / cellular response to amino acid stimulus / protein catabolic process / positive regulation of protein-containing complex assembly / metalloendopeptidase activity / cellular response to reactive oxygen species / metallopeptidase activity / peptidase activity / cellular response to lipopolysaccharide / Interleukin-4 and Interleukin-13 signaling / endopeptidase activity / Extra-nuclear estrogen signaling / serine-type endopeptidase activity / innate immune response / mitochondrion / proteolysis / extracellular space / zinc ion binding / extracellular region / nucleus / cytosol Similarity search - Function | ||||||
Biological species | Homo sapiens (human) | ||||||
Method | SOLUTION NMR | ||||||
Authors | Van Doren, S.R. / Kurochkin, A.V. / Hu, W. / Zuiderweg, E.R.P. | ||||||
Citation | Journal: Protein Sci. / Year: 1995 Title: Solution structure of the catalytic domain of human stromelysin complexed with a hydrophobic inhibitor. Authors: Van Doren, S.R. / Kurochkin, A.V. / Hu, W. / Ye, Q.Z. / Johnson, L.L. / Hupe, D.J. / Zuiderweg, E.R. #1: Journal: Biochemistry / Year: 1993 Title: Assignments for the Main-Chain Nuclear Magnetic Resonances and Delineation of the Secondary Structure of the Catalytic Domain of Human Stromelysin-1 as Obtained from Triple-Resonance 3D NMR Experiments Authors: Van Doren, S.R. / Kurochkin, A.V. / Ye, Q.-Z. / Johnson, L.L. / Hupe, D.J. / Zuiderweg, E.R.P. | ||||||
History |
|
-Structure visualization
Structure viewer | Molecule: MolmilJmol/JSmol |
---|
-Downloads & links
-Download
PDBx/mmCIF format | 1ums.cif.gz | 1 MB | Display | PDBx/mmCIF format |
---|---|---|---|---|
PDB format | pdb1ums.ent.gz | 859.3 KB | Display | PDB format |
PDBx/mmJSON format | 1ums.json.gz | Tree view | PDBx/mmJSON format | |
Others | Other downloads |
-Validation report
Summary document | 1ums_validation.pdf.gz | 458.3 KB | Display | wwPDB validaton report |
---|---|---|---|---|
Full document | 1ums_full_validation.pdf.gz | 733.2 KB | Display | |
Data in XML | 1ums_validation.xml.gz | 117.5 KB | Display | |
Data in CIF | 1ums_validation.cif.gz | 140 KB | Display | |
Arichive directory | https://data.pdbj.org/pub/pdb/validation_reports/um/1ums ftp://data.pdbj.org/pub/pdb/validation_reports/um/1ums | HTTPS FTP |
-Related structure data
-Links
-Assembly
Deposited unit |
| |||||||||
---|---|---|---|---|---|---|---|---|---|---|
1 |
| |||||||||
Atom site foot note | 1: CIS PROLINE - PRO A 87 MODEL 1 / 2: CIS PROLINE - PRO A 109 MODEL 1 3: THR A 128 - PRO A 129 MODEL 1 OMEGA = 140.08 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 4: TYR A 155 - PRO A 156 MODEL 1 OMEGA = 211.20 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 5: TYR A 220 - PRO A 221 MODEL 1 OMEGA = 220.00 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 6: CIS PROLINE - PRO A 87 MODEL 2 7: THR A 128 - PRO A 129 MODEL 2 OMEGA = 140.45 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 8: CIS PROLINE - PRO A 87 MODEL 3 9: THR A 128 - PRO A 129 MODEL 3 OMEGA = 137.29 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 10: TYR A 220 - PRO A 221 MODEL 3 OMEGA = 229.78 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 11: THR A 128 - PRO A 129 MODEL 4 OMEGA = 131.14 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 12: TYR A 155 - PRO A 156 MODEL 4 OMEGA = 218.19 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 13: GLY A 159 - PRO A 160 MODEL 4 OMEGA = 222.63 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 14: ALA A 169 - PRO A 170 MODEL 4 OMEGA = 245.06 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 15: CIS PROLINE - PRO A 87 MODEL 5 16: THR A 128 - PRO A 129 MODEL 5 OMEGA = 143.79 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 17: CIS PROLINE - PRO A 87 MODEL 6 18: THR A 128 - PRO A 129 MODEL 6 OMEGA = 136.67 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 19: TYR A 220 - PRO A 221 MODEL 6 OMEGA = 225.35 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 20: CIS PROLINE - PRO A 87 MODEL 7 21: THR A 128 - PRO A 129 MODEL 7 OMEGA = 141.81 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 22: CIS PROLINE - PRO A 172 MODEL 7 23: TYR A 220 - PRO A 221 MODEL 7 OMEGA = 229.18 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 24: CIS PROLINE - PRO A 87 MODEL 8 25: ILE A 89 - PRO A 90 MODEL 8 OMEGA = 223.00 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 26: THR A 128 - PRO A 129 MODEL 8 OMEGA = 143.14 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 27: GLY A 159 - PRO A 160 MODEL 8 OMEGA = 221.57 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 28: CIS PROLINE - PRO A 90 MODEL 9 / 29: CIS PROLINE - PRO A 87 MODEL 10 30: THR A 128 - PRO A 129 MODEL 10 OMEGA = 137.84 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 31: CIS PROLINE - PRO A 87 MODEL 11 32: ILE A 89 - PRO A 90 MODEL 11 OMEGA = 148.36 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 33: THR A 128 - PRO A 129 MODEL 11 OMEGA = 143.18 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 34: CIS PROLINE - PRO A 87 MODEL 12 35: THR A 128 - PRO A 129 MODEL 12 OMEGA = 141.31 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 36: GLY A 159 - PRO A 160 MODEL 12 OMEGA = 214.44 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 37: CIS PROLINE - PRO A 87 MODEL 13 38: THR A 128 - PRO A 129 MODEL 13 OMEGA = 139.16 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 39: TYR A 155 - PRO A 156 MODEL 13 OMEGA = 255.71 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 40: ALA A 169 - PRO A 170 MODEL 13 OMEGA = 305.81 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 41: TYR A 220 - PRO A 221 MODEL 13 OMEGA = 221.23 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 42: CIS PROLINE - PRO A 87 MODEL 14 43: THR A 128 - PRO A 129 MODEL 14 OMEGA = 137.86 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 44: TYR A 220 - PRO A 221 MODEL 14 OMEGA = 225.10 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 45: CIS PROLINE - PRO A 87 MODEL 15 46: THR A 128 - PRO A 129 MODEL 15 OMEGA = 142.51 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 47: CIS PROLINE - PRO A 87 MODEL 16 48: THR A 128 - PRO A 129 MODEL 16 OMEGA = 141.90 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 49: TYR A 155 - PRO A 156 MODEL 16 OMEGA = 256.07 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 50: CIS PROLINE - PRO A 87 MODEL 17 51: ILE A 89 - PRO A 90 MODEL 17 OMEGA = 239.90 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 52: THR A 128 - PRO A 129 MODEL 17 OMEGA = 139.00 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 53: CIS PROLINE - PRO A 172 MODEL 17 / 54: CIS PROLINE - PRO A 87 MODEL 18 55: THR A 128 - PRO A 129 MODEL 18 OMEGA = 137.94 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 56: CIS PROLINE - PRO A 156 MODEL 18 57: ALA A 169 - PRO A 170 MODEL 18 OMEGA = 319.53 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 58: CIS PROLINE - PRO A 172 MODEL 18 59: TYR A 220 - PRO A 221 MODEL 18 OMEGA = 235.68 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 60: CIS PROLINE - PRO A 87 MODEL 19 61: THR A 105 - PRO A 106 MODEL 19 OMEGA = 211.53 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 62: THR A 128 - PRO A 129 MODEL 19 OMEGA = 142.69 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 63: TYR A 155 - PRO A 156 MODEL 19 OMEGA = 243.41 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 64: CIS PROLINE - PRO A 87 MODEL 20 65: THR A 128 - PRO A 129 MODEL 20 OMEGA = 128.85 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 66: TYR A 220 - PRO A 221 MODEL 20 OMEGA = 230.10 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION | |||||||||
NMR ensembles |
|
-Components
#1: Protein | Mass: 19513.646 Da / Num. of mol.: 1 / Fragment: CATALYTIC DOMAIN RESIDUES 83 - 256 Source method: isolated from a genetically manipulated source Source: (gene. exp.) Homo sapiens (human) / Description: INDUCTION BY M13 WITH T7 RNA POLYMERASE / Gene: HUMAN STROMELYSIN-1 CATALYTIC / Plasmid: PGEMEX-D Gene (production host): HUMAN STROMELYSIN-1 CATALYTIC DOMAIN Production host: Escherichia coli (E. coli) / References: UniProt: P08254, stromelysin 1 | ||||
---|---|---|---|---|---|
#2: Chemical | #3: Chemical | ChemComp-CA / | #4: Chemical | ChemComp-0DS / | |
-Experimental details
-Experiment
Experiment | Method: SOLUTION NMR |
---|
-Sample preparation
Crystal grow | *PLUS Method: other |
---|
-Processing
NMR software |
| |||||||||
---|---|---|---|---|---|---|---|---|---|---|
NMR ensemble | Conformers submitted total number: 20 |